GNW Genworth Financial (GNW) Insider Trading, Ownership & Congress Trades
Insurance · Life insurance · CIK 0001276520
Form 144 · 3
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · no price filed
What the filings say about GNW
Insiders, 180 days
-$3.0M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-06-17
Planned sales (Form 144), 90 days
$1.6M
3 notices
Genworth Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, GENWORTH FINANCIAL INC insiders sold a net $3.0M of stock across 22 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on May 22, 2026.
- The trade is 2.0% of the 5,068,883 shares held after it.
- 2 other insiders sold within 30 days.
Insider activity: President and CEO; Director McInerney Thomas J sold about $1.1M of GNW on Sep 3, 2026, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 7.6% of the 192,539 shares held after it.
- 2 other insiders sold within 30 days.
Insider activity: EVP and Chief HR Officer Hagerman Melissa sold about $145.8K of GNW on Aug 24, 2026; 2 other insiders sold within 30 days.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Nov 24, 2025.
- The trade is 11.7% of the 343,121 shares held after it.
- 2 other insiders sold within 30 days.
Insider activity: EVP and General Counsel Karawan Gregory S. sold about $396.5K of GNW on Aug 21, 2026; 2 other insiders sold within 30 days.Context
- 11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Dec 2, 2025.
- The trade is 1.9% of the 5,368,883 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: President and CEO; Director McInerney Thomas J sold about $927.0K of GNW on May 22, 2026, the largest insider sale at the company since 2024; 1 other insider sold within 30 days.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Feb 4, 2022.
- The trade is 54.0% of the 92,655 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Director RESTREPO ROBERT P JR sold about $456.0K of GNW on May 22, 2026; 1 other insider sold within 30 days.22 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$3.0M over 180 days
-$1.6M over 90 days
below 52% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+0.1% year over year
below 78% of Insurance
Margin
3.1% net margin
below 73% of Insurance
Buybacks
$130.0M repurchased, FY to 2026-06-30
below 54% of Insurance
Short interest
2.3% of the float short (float per yahoo 2026-10-26) · 1.8 days to cover · settled 2026-09-30
below 66% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch GNW
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+4.6%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns GNW: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in GNW
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Bought 2025-06-11 · disclosed 63 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
GNW planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
McInerney Thomas J
Filed 2026-09-03
$1.1M
Hagerman Melissa
Filed 2026-08-24
$145.8K
Karawan Gregory S.
Filed 2026-08-21
$396.0K
Executive pay vs shareholder return · Mr. Thomas McInerney
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$9.9M
$14.4M
$3.0M
+52%
-2%
2022
$9.4M
$13.4M
$3.2M
+20%
-10%
2021
$8.5M
$20.1M
$4.8M
-8%
+8%
2020
$7.4M
$14.2M
$5.6M
-14%
+3%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $3.0M sold by insiders over 180 days, $1.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
GNW financials
Revenue growth
+0.1%
XBRL, annual
Net margin
3.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$7.4B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GNW
| FY Dec 2025 | $7.3B |
| FY Dec 2024 | $7.3B |
| FY Dec 2023 | $7.5B |
| FY Dec 2022 | $7.5B |
| FY Dec 2021 | $7.8B |
| Jun 2026 | $1.9B |
| Mar 2026 | $1.8B |
| Dec 2025 | $1.8B |
| Sep 2025 | $1.9B |
| Jun 2025 | $1.8B |
| Mar 2025 | $1.8B |
| Dec 2024 | $1.8B |
| Sep 2024 | $1.9B |
At each fiscal year end
Single quarter
Net margin, TTM
+2.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GNW
| FY Dec 2025 | +3.1% |
| FY Dec 2024 | +4.1% |
| FY Dec 2023 | +1.0% |
| FY Dec 2022 | +12.2% |
| FY Dec 2021 | n/a |
| Jun 2026 | +2.5% |
| Mar 2026 | +2.6% |
| Dec 2025 | +0.1% |
| Sep 2025 | +6.0% |
| Jun 2025 | +2.8% |
| Mar 2025 | +3.0% |
| Dec 2024 | -0.1% |
| Sep 2024 | +4.5% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM GNW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.17x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity GNW
| FY Dec 2025 | 0.17x |
| FY Dec 2024 | 0.18x |
| FY Dec 2023 | 0.21x |
| FY Dec 2022 | 0.21x |
| FY Dec 2021 | 0.12x |
| Jun 2026 | 0.17x |
| Mar 2026 | 0.17x |
| Dec 2025 | 0.17x |
| Sep 2025 | 0.17x |
| Jun 2025 | 0.17x |
| Mar 2025 | 0.17x |
| Dec 2024 | 0.18x |
| Sep 2024 | 0.19x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.29x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt GNW
| FY Dec 2025 | 0.22x |
| FY Dec 2024 | 0.06x |
| FY Dec 2023 | 0.73x |
| FY Dec 2022 | 0.65x |
| FY Dec 2021 | 0.23x |
| Jun 2026 | 0.29x |
| Mar 2026 | 0.25x |
| Dec 2025 | 0.22x |
| Sep 2025 | 0.10x |
| Jun 2025 | 0.15x |
| Mar 2025 | 0.15x |
| Dec 2024 | 0.06x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GNW
| FY Dec 2025 | +2.6% |
| FY Dec 2024 | +3.8% |
| FY Dec 2023 | +1.0% |
| FY Dec 2022 | +7.9% |
| FY Dec 2021 | n/a |
| Jun 2026 | +2.4% |
| Mar 2026 | +2.5% |
| Dec 2025 | +2.6% |
| Sep 2025 | +2.6% |
| Jun 2025 | +2.2% |
| Mar 2025 | +2.6% |
| Dec 2024 | +3.8% |
| Sep 2024 | +1.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GNW
| FY Dec 2025 | +0.3% |
| FY Dec 2024 | +0.3% |
| FY Dec 2023 | +0.1% |
| FY Dec 2022 | +1.0% |
| FY Dec 2021 | n/a |
| Jun 2026 | +0.2% |
| Mar 2026 | +0.2% |
| Dec 2025 | +0.3% |
| Sep 2025 | +0.2% |
| Jun 2025 | +0.2% |
| Mar 2025 | +0.2% |
| Dec 2024 | +0.3% |
| Sep 2024 | +0.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GNW
| FY Dec 2025 | n/a |
| FY Dec 2024 | +0.2% |
| FY Dec 2023 | +0.3% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | +3.9% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | +0.2% |
| Sep 2024 | +0.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GNW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
16.81x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GNW
| FY Dec 2025 | 16.72x |
| FY Dec 2024 | 10.43x |
| FY Dec 2023 | 55.67x |
| FY Dec 2022 | 2.94x |
| FY Dec 2021 | 2.29x |
| Jun 2026 | 17.87x |
| Mar 2026 | 15.32x |
| Dec 2025 | 16.72x |
| Sep 2025 | 16.79x |
| Jun 2025 | 17.68x |
| Mar 2025 | 14.47x |
| Dec 2024 | 10.43x |
| Sep 2024 | 34.25x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.8B
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term debt only, 2026-06-30, minus cash 2020-12-31
Enterprise value GNW
| FY Dec 2025 | $4.1B |
| FY Dec 2024 | $3.5B |
| FY Dec 2023 | $3.6B |
| FY Dec 2022 | $3.2B |
| FY Dec 2021 | $2.9B |
| Jun 2026 | $4.1B |
| Mar 2026 | $3.6B |
| Dec 2025 | $4.1B |
| Sep 2025 | $4.1B |
| Jun 2025 | $3.7B |
| Mar 2025 | $3.5B |
| Dec 2024 | $3.5B |
| Sep 2024 | $3.5B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield GNW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.82x
P/E over trailing EPS growth of 20%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing GNW
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.02x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 1.73x |
| FY Dec 2021 | 0.01x |
| Jun 2026 | 0.87x |
| Mar 2026 | 1.88x |
| Dec 2025 | n/a |
| Sep 2025 | 0.10x |
| Jun 2025 | 0.03x |
| Mar 2025 | 0.09x |
| Dec 2024 | 0.02x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $7.3B | $7.3B | $7.5B | $7.5B |
| Operating income | n/a | n/a | $41.0M | $818.0M |
| Net income | $223.0M | $299.0M | $76.0M | $916.0M |
| EPS (diluted) | 0.54 | 0.68 | 0.16 | 1.79 |
| Operating cash flow | $327.0M | $88.0M | $597.0M | $1.0B |
| Long-term debt | $1.5B | $1.5B | $1.6B | $1.6B |
| Buybacks | $247.0M | $189.0M | $296.0M | $64.0M |
SEC XBRL, fiscal years, as known on 2026-10-28
GNW Stock Sonar score 6/7 axes
Find similar shapesCompareGNW ranks highest on institutional and government (76th percentile) and risk and compliance (62nd), and lowest on profitability (17th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GNW filings, in plain words
Are Genworth Financial insiders buying or selling GNW?
In the 180 days to 2026-10-28, Genworth Financial insiders were net sellers, a net $3.0M across purchases and sales reported on Form 4, by 4 sellers.
Have members of Congress traded GNW?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-06-17.
Are there planned insider sales of GNW?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.6M of stock; the latest, by McInerney Thomas J, was filed 2026-09-03.
Read the full summary
In the 180 days to 2026-10-28, Genworth Financial insiders were net sellers of GNW, a net $3.0M across purchases and sales reported on Form 4 by 4 sellers. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in GNW, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-06-17. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
